BioImagene Announces Appointment of ForteBio CEO - Dr Joseph D. Keegan to
its Board of Directors
Cupertino, Jan 15, 2008
BioImagene, a leading provider of innovative imaging software and systems for cancer
diagnosis and research is pleased to announce Dr Joseph Keegan’s appointment as a
director to the company’s board.
Dr. Keegan brings over 25 years’ management experience in the life sciences tools
industry. He is currently the President and CEO of ForteBio Inc. Previously Dr Keegan
was the CEO of Molecular Devices (MDC). During his 9-year tenure at MDC, Dr Keegan
grew the company's revenues from $30 million to $190 million and in early 2007 he
oversaw its acquisition by MDS for $615 million. Prior to MDC, Dr Keegan served in
Becton Dickinson and company as President of Worldwide Tissue Culture. His executive
management experience also includes Leica, Inc. where he was Vice President of
Microscopy and Scientific Instruments Division.
“It is a pleasure to welcome Dr Keegan to our Board at a time when the company is
experiencing significant growth. Joe’s extensive medical device experience and proven
track record of building and managing life science companies will be a significant asset
to Bioimagene and its board of directors. Joe’s appointment will strengthen the board’s
ability to effectively guide BioImagene in its efforts to become a leading digital pathology
solutions company,” said Mohan Uttarwar, BioImagene CEO.
“I am pleased about my appointment to the BioImagene Board at this stage of the
company’s development. It is an exciting time as more companies and laboratories are
using digital pathology systems. BioImagene is well positioned to increase its market
presence with a strong product pipeline. I look forward to helping BioImagene expand its
successful business.” commented Dr Keegan.
About BioImagene
BioImagene is a leading provider of total digital pathology solutions for applications
including clinical diagnostics and drug discovery. Our mission is to bring affordable
digital pathology to every pathologist in every laboratory worldwide. Our systems
automate pathology workflows for acquisition, analysis, management, archival, reporting
and sharing of tissue images.
Media Contact: Suchitra Parth. 408 207 4285. www.bioimagene.com
|
